	US 11,793,818 B2
	Method for treating conditions associated with hyperproliferating cells comprising combined administration of a cannabinoid receptor agonist and radiation therapy
Roger Dumoulin-White, Toronto (CA); and Arkady Mandel, North York (CA)
Assigned to THERALASE TECHNOLOGIES, INC., Toronto (CA)
Filed by Theralase Technologies, Inc., Toronto (CA)
Filed on Mar. 26, 2019, as Appl. No. 16/365,148.
Claims priority of provisional application 62/648,334, filed on Mar. 26, 2018.
Prior Publication US 2019/0290657 A1, Sep. 26, 2019
Int. Cl. A61K 31/555 (2006.01); A61K 41/00 (2020.01); A61K 47/64 (2017.01); A61K 31/352 (2006.01)

CPC A61K 31/555 (2013.01) [A61K 31/352 (2013.01); A61K 41/0057 (2013.01); A61K 47/644 (2017.08)]

20 Claims

1. A method for treating cancer, said method comprising the steps of:

(a) administering to a subject having cancer cells a composition comprising at least one cannabinoid receptor agonist;

(b) administering to the subject a photodynamic compound; and

(c) administering radiation to the subject in whom the at least one cannabinoid receptor agonist and the photodynamic compound are present so as to activate the photodynamic compound to generate at least one of radicals and reactive oxygen species to destroy the cancer cells to treat the cancer.